We are live on ! Find out more
Broadfin Capital

Broadfin Capital Portfolio holdings

AUM $747M Turnover 50%
1-Year Est. Return 100.56%
This Fund
S&P 500
This Quarter Est. Return
+43.75%
1 Year Est. Return
+100.56%
3 Year Est. Return
+297.65%
5 Year Est. Return
+365.91%
10 Year Est. Return
–
AUM
$747M
AUM Growth
+$206M
Cap. Flow
-$7.76M
Cap. Flow %
-1.04%
Top 10 Hldgs %
63.69%
Holding
56
New
12
Increased
11
Reduced
13
Closed
16
Avg Time Held Equity + Options
1.4 years
Top 10 Avg Time Held Equity + Options
0.3 years
Top 20 Avg Time Held Equity + Options
0.5 years
Avg Time Held Equity only
1.6 years
Top 10 Avg Time Held Equity only
0.3 years
Top 20 Avg Time Held Equity only
0.5 years

Top Buys

Rank Stock Value
1
ALKS icon
Alkermes
ALKS
+$15.6M
2
STAA icon
STAAR Surgical
STAA
+$15.2M
3
LJPC
La Jolla Pharmaceutical Company
LJPC
+$14.8M
4
LNTH icon
Lantheus
LNTH
+$12.5M
5
QTNT
Quotient Limited Ordinary Shares
QTNT
+$11.4M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$16.2M
2
IOVA icon
Iovance Biotherapeutics
IOVA
+$13.6M
3
NVRO icon
NEVRO CORP.
NVRO
+$12.9M
4
WMGI
Wright Medical Group Inc
WMGI
+$12.8M
5
ABBV icon
AbbVie
ABBV
+$11.7M

Sector Composition

Rank Sector Weight
1 Healthcare 53.91%
2 Miscellaneous 46.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ATRS
51
DELISTED
Antares Pharma, Inc.
ATRS
– –
-1,336,700
Closed -$4.47M –
SBBP
52
DELISTED
Strongbridge Biopharma plc.
SBBP
– –
-2,578,003
Closed -$6.16M –
GWPH
53
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-30,000
Closed -$3.45M –
AMAG
54
DELISTED
AMAG Pharmaceuticals
AMAG
– –
-100,000
Closed -$1.16M –
WMGI
55
DELISTED
Wright Medical Group Inc
WMGI
– –
-618,500
Closed -$12.8M –
AGN
56
DELISTED
Allergan plc
AGN
– –
-96,504
Closed -$16.2M –
1 2
3

Similar funds

CIBC Bank USA
CIBC Bank USA Chicago, Illinois $756M AUM 24.68% 1-Year Est. Return
Capital One National Association
Capital One National Association New York $756M AUM
Manikay Partners
Manikay Partners New York $893M AUM 55.39% 1-Year Est. Return
SC
Selz Capital New York $570M AUM 35.56% 1-Year Est. Return
Kopernik Global All-Cap Fund
Kopernik Global All-Cap Fund Tampa, Florida $558M AUM
Beacon Pointe Wealth Advisors
Beacon Pointe Wealth Advisors Newport Beach, California $543M AUM 23.61% 1-Year Est. Return
Tuscan Ridge Asset Management
Tuscan Ridge Asset Management Chicago, Illinois $984M AUM 25.8% 1-Year Est. Return
VHCP Management III
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return

Broadfin Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Broadfin Capital held 56 positions worth $747M, up 38% from $541M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Broadfin Capital's Q4 2019 filing shows 12 new, 11 increased, 13 reduced and 16 closed positions. Its largest new stake was STAAR Surgical: 462,118 shares worth $16.3M. The largest sale was Allergan plc, an estimated $16.2M.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, down from 59% a quarter earlier, followed by Miscellaneous.

  • Broadfin Capital's largest Q4 2019 buy was STAAR Surgical: 462,118 shares worth $16.3M.
  • Broadfin Capital added most to Alkermes in Q4 2019, an estimated $15.6M increase.
  • Broadfin Capital's biggest Q4 2019 reduction was Iovance Biotherapeutics, cutting an estimated $13.6M.
  • Broadfin Capital fully exited Allergan plc in Q4 2019, selling an estimated $16.2M.
  • Broadfin Capital's ten largest holdings make up 64% of its $747M portfolio in Q4 2019.
  • Broadfin Capital opened 12 new positions and closed 16 in Q4 2019.
  • Broadfin Capital's portfolio value rose 38% quarter-over-quarter to $747M.

Based on Broadfin Capital's 13F filing for Q4 2019, filed 14 Feb 2020.